1. Coons, A. H., Creech, H. J., and Jones R. N. Immunological properties of an antibody containing a fluorescent group. Proc. Soc. Exp. Biol. 47:200-202, 1941.

2. Taylor, C. R., and Burns, J. The demonstration of plasma cells and other immunoglobulin containing cells in formalin-fixed, paraffin-embedded tissues using peroxidase labeled antibody. J. Clin. Pathol. 27:14-20, 1974.

3. Kohler, G., and Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495-497, 1975.

4. Huang, S.-N. Immunohistochemical demonstration of hepatitis B core and surface antigens in paraffin sections. Lab. Invest. 33:88-95, 1975.

5. Shi, S. R., Key, M. E., and Kalra, K. L. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J. Histochem. Cytochem. 39:741-748, 1991.

6. Dabbs, D. J. Diagnostic Immunohistochemistry. Churchill, New York, Livingstone, 2002.

7. Taylor, C. Immunomicroscopy: A Diagnostic Tool for the Surgical Pathologist. Major Problems in Pathology Vol. 19, 1994.

8. Hsi, E. D. A practical approach for evaluating new antibodies in the clinical immunohistochemistry laboratory. Arch. Pathol. Lab. Med. 125:289-294, 2001.

9. Werner, M., Chott, A., Fabriano, A., and Battifora, H. Effect of formalin tissue fixation and processing on immunohistochemistry. Am. J. Surg. Pathol. 24:1016-1019, 2000.

10. Shi, S. R., Cote, R. J., and Taylor, C. R. Antigen retrieval immuno-histochemistry: past, present, and future. J. Histochem. Cytochem. 45:327-343, 1997.

11. Shi, S. R., Cote, R. J., and Taylor, C. R. Antigen retrieval immunohistochemistry and molecular morphology in the year 2001. Appl. Immunohistochem. Mol. Morphol. 9:107-116, 2001.

12. Huang, S.-N. Immunohistochemical demonstration of hepatitis B core and surface antigens in paraffin sections. Lab. Invest. 33:88-95, 1975.

13. Rodney, M. T., Swanson, P., and Wick, M. R. Fixation and epitope retrieval in diagnostic immunohistochemistry: a concise review with practical considerations. Appl. Immunohistochem. 8:228-235, 2000.

14. Cattoretti, G. and Suurmeijer, A. J. H. Antigen unmasking on formalin-fixed paraffin-embedded tissue using microwaves: a review. Adv. Anat. Pathol. 2:2-9, 1995.

15. Cuevas, E. C., Bateman, A. C., Wilkins, B. S., et al. Microwave antigen retrieval in immunohistochemistry: a study of 80 antibodies. J. Clin. Pathol. 47:448-452, 1994.

16. Taylor, C. R., Shi, S. R., Chaiwun, B., Young, L., Imam, A., and Cote, R. J. Strategies for improving the immunohistochemical staining of various intranuclear prognostic markers in formalin-paraffin sections: androgen receptor, estrogen receptor, progesteron receptor, p53, PCNA, and Ki-67 antigen revealed by antigen retrieval technique. Hum. Pathol. 25:1107-1109, 1994.

17. Linden, M. D., Nathanson, S. D., and Zarbo, R. J. Evaluation of p53 antibody staining immunoreactivity in benign tumors and nonneo-plastic tissues. Appl. Immunohistochem. 3:232-238, 1995.

18. Hsu, S. M., Raine, L., and Fanger, H. Use of avidin-biotin peroxi-dase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29:577-580, 1981.

19. Bisgaard, K. and Pluzek, K. Use of polymer conjugates in immunohistochemistry: a comparative study of a traditional staining method to a staining method using polymer conjugates. Pathol. Int. 46(Suppl. 1):577, 1996.

20. Vyberg, M. and Nielsen, S. Dextran: polymer conjugate two-step visualization system for immunohistochemistry. Appl. Immuno-histochem. 6:3-10, 1998.

21. Sabattini, E., Bisgaard, K., Ascani, S., et al. The Envision++ system: a new immunohistochemical method for diagnostic and research; critical comparison with APAAP, ChemMate, CSA, LABC, SABC techniques. J. Clin. Pathol. 51:506-511, 1998.

22. Shi, S., Guo, J., Cote, R. J., et al. Sensitivity and detection efficiency of a novel two-step detection system (PowerVision) for immunohistochemistry Appl. Immunohistochem. Mol. Morphol. 7:201-208, 1999.

23. Richter, T., Nahrig, J., Komminoth, P., Kowolik, J., and Werner, M. Protocol for ultrarapid immunostaining of frozen sections. J. Clin. Pathol. 52:461-463. 1999.

24. Bobrow, M. N., Harris, T. D., Shaughnessy, K. J., and Litt, G. J. Catalyzed reporter deposition, a novel method of signal amplification; application to immunoassays. J. Immunol. Methods. 125:279289, 1989.

25. Adams, J. C. Biotin amplification of biotin and horseradish peroxi-dase signals in histochemical stains. J. Histochem. Cytochem. 40: 457-1463, 1992.

26. Grogan, T. M. Automated immunohistochemical analysis. Am. J. Clin. Pathol. 98(Suppl. 1):S35-S38, 1992.

27. Le Neel, T., Moreau, A., Laboisse, C., and Truchaud, A. Comparative evaluation of automated systems in immunohisto-chemistry. Clin. Chim. Acta. 278:185-192, 1998.

28. Seidal, T., Balaton, A., and Battifora, H. Interpretation and quantification of immunostains. Am. J. Surg. Pathol. 25:1204-1207, 2001.

29. Van Wasielewski, R., Mengel, M., Wiese, B., Rüdiger, T., MüllerHermelink, H. K., and Kreipe, H. Tissue array technology for testing interlaboratory and interobserver reproducibility of immuno-histochemical estrogen receptor analysis in a large multicenter trial. Am. J. Clin. Pathol. 118:675-682, 2002.

30. Cartun, R. W. Immunohistochemistry in infectious diseases. J. Histotechnol. 18:195-202, 1995.

31. Cohen, J. Epstein-Barr virus infection. N. Engl. J. Med. 343: 481-492, 2000.

32. Hsu, J. L., and Glaser, S. L. Epstein-Barr virus-associated malignancies: epidemiologic patterns and etiologic implications. Crit. Rev. Oncol. Hematol. 34:27-53, 2000.

33. Herrmann, K., and Niedobitek, G. Epstein-Barr virus-associated carcinomas: facts and fiction. J. Pathol. 199:140-145, 2003.

34. Swaminathan, S. Molecular biology of Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus. Semin. Hematol. 40:107-115,2003.

35. Gulley, M. L. Molecular diagnosis of Epstein-Barr virus-related diseases. J. Mol. Diagn. 3:1-19, 2001.

36. Courville, P., Simon, F., Le Pessot, F., Tallet, Y., Debab, Y., and Metayer, J. Detection of HHV8 latent nuclear antigen by immuno-histochemistry: a new tool for differentiating Kaposi's sarcoma from its mimics. Ann. Pathol. 22:264-276, 2002.

37. Negri, G., Egarter-Vigl, E., Kasal, A., Romano, F., Haitel, A., and Mian, C. p16INK4a is a useful marker for the diagnosis of adeno-carcinoma of the cervix uteri and its precursors: an immunohisto-chemical study with immunocytochemical correlations. Am. J. Surg. Pathol. 27:187-193, 2003.

38. Riethdorf, L., Riethdorf, S., Lee, K. R., Cviko, A., Loning, T., and Crum, C. P. Human papillomaviruses, expression of p16, and early endocervical glandular neoplasia. Hum. Pathol. 33:899-904, 2002.

39. Chan, J. K. Advances in immunohistochemistry: impact on surgical pathology practice. Semin. Diagn. Pathol. 17:170-177, 2000.

40. Kaufmann, O., Fietze, E., and Dietel, M. Immunohistochemical diagnosis in cancer metastasis of unknown primary tumor. Pathologie 23:183-197, 2002.

41. Chu, P., Wu, E., and Weiss, L. M. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod. Pathol. 13:962-972, 2000.

42. Harris, N. L., Jaffe, E. S., Stein, H., et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84:1361-1392, 1994.

43. Harris, N. L., Jaffe, E. S., Diebold, J., et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lym-phoid tissues: report of the Clinical Advisory Committee meet-ing-Airlie House, Virginia, November 1997. J. Clin. Oncol. 17:3835-3849, 1999.

44. Torlakovic, E., Torlakovic, G., Nguyen, P. L., Brunning, R. D., and Delabie, J. The value of anti-pax-5 immunostaining in routinely fixed and paraffin-embedded sections: a novel pan pre-B and B-cell marker. Am. J. Surg. Pathol. 26:1343-1350, 2002.

45. Wang, T., Lasota, J., Hanau, C. A., and Miettinen, M. Bcl-2 onco-protein is widespread in lymphoid tissue and lymphomas but its differential expression in benign versus malignant follicles and monocytoid B-cell proliferations is of diagnostic value. APMIS 103:655-662, 1995.

46. Kurtin, P. J., Hobday, K. S., Ziesmer, S., and Caron, B. L. Demonstration of distinct antigenic profiles of small B-cell lymphoma by paraffin section immunohistochemistry. Am. J. Clin. Pathol. 112:319-329, 1999.

47. Zukerberg, L. R., Yang, W. I., Arnold, A., and Harris, N. L. Cyclin D1 expression in non-Hodgkin's lymphomas. Detection by immunohistochemistry. Am. J. Clin. Pathol. 103:756-760, 1995.

48. Xu, Y., McKenna, R. W., Molberg, K. H., and Kroft, S. H. Clinicopathologic analysis of CD10+ and CD10- diffuse large B-cell lymphomas. Identification of a high-risk subset with coexpres-sion of CD10 and bcl-2. Am. J. Clin. Pathol. 116:183-190, 2001.

49. Lossos, I. S., Jones, C. D., Warnke, R., et al. Expression of a single gene, bcl-6, strongly predicts survival in patients with diffuse large B-cell lymphoma. Blood 98:945-951, 2001.

50. Marshall-Taylor, C. E., Cartun, R. W., Mandich, D., and DiGiuseppe, J. A. Immunohistochemical detection of immunoglob-ulin light chain expression in B-cell non-Hodgkin lymphomas using paraffin-fixed, paraffin-embeded tissues and a heat-induced epitope retrieval technique. Appl. Immunohistochem. Mol. Morphol. 10:258-262, 2002.

51. Leong, A. S.-Y., Yin, H., and Hafajee, Z. Patterns of immunoglobu-lin staining in paraffin-embedded malignant lymphomas. Appl. Immunohistochem. Mol. Morphol. 10:110-114, 2002.

52. Kinney, M. C. The role of morphologic features, phenotype, genotype and anatomic site in defining extranodal T-cell or NK-cell neoplasms. Am. J. Clin. Pathol. 111(1 Suppl 1):S104-S118, 1999.

53. Ohno, T., Stribley, J. A., Wu, G., Hinrichs, S. H., Weisenburger, D. D., and Chan, W. C. Conality in nodular lymphocyte-predominant Hodgkin's disease. N. Engl. J. Med. 14:459-465, 1997.

54. Stein, H., Marafioti, T., Foss, H. D., et al. Down-regulation of BOB.1/OBF. 1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglob-ulin transcription. Blood 97:496-501, 2001.

55. Vasef, M. A., Alsabeh, R., Madeiros, L. J., and Weiss, L. M. Immuno-phenotype of Reed-Sternberg and Hodgkin's cells in sequential specimens of Hodgkin's disease: a paraffin section immunohisto-chemical study using heat-induced epitope retrieval method. Am. J. Clin. Pathol. 108:54-59, 1997.

56. Kelly, K. M., Womer, R. B., Sorensen, P. H., Xiong, Q. B., and Barr, F. G. Common and variant gene fusions predict distinct clinical phe-notypes in rhabdomyosarcomas. J. Clin. Oncol. 15:1831-1836, 1997.

57. Delattre, O., Zucman, J., Melot, T., The Ewing family of tumors-- a subgroup of small round cell tumors defined by specific chimeric transcripts. N. Engl. J. Med. 331:294-299, 1994.

58. Gerald, W. L., Ladanyi, M., de Alava, E., Cuatrecasas, M., Kushner, B. H., and LaQuaglia, M. P. Clinical pathologic and molecular spectrum of tumors associated with t(11;22)(p13;q12): desmoplastic small round-cell tumor and its variants. J. Clin. Oncol. 6:3028-3036, 1998.

59. Adams, V., Hany, M. A., Schmidt, M., Hassam, S., Briner, J., and Niggli, F. K. Detection of t(11;22)(q24;q12) translocation breakpoint in paraffin embedded tissue of the Ewing's sarcoma family by nested reverse transcription-polymerase chain reaction. Diagn. Mol. Pathol. 5:107-113, 1996.

60. Parham, D. M., Webber, B., Holt, H., William, W. K., and Maurer, H. Immunohistochemical studies of childhood rhabdomyosarcomas and related neoplasms. Result of an intergroup rhabdomyosarcoma study project. Cancer 67:3072-3080, 1991.

61. Wang, N. P., Marx, J., McNutt, M. A., Rutledge, J. C., and Gown, A. M. Expression of myogenic regulatory proteins (myogenin and Myo D1) in small blue cell tumors of childhood. Am. J. Pathol. 147:1799-1810, 1995.

62. Cessna, M. H., Zhou, H., Perkins, S. L., et al. Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases with emphasis on spindle cell mimics. Am. J. Surg. Pathol. 25:1150-1157, 2001.

63. Perlman, E. J., Dickman, P. S., Askin, F. B., Grier, H. E., Miser, J. S., and Link, M. P. Ewing's sarcoma—routine diagnostic utilization of MIC2 analysis -- a Pediatric Oncology Group/Children's Cancer Group Intergroup Study. Hum. Pathol. 25:304-307, 1994.

64. Folpe, A. L., Hill, C. E., Parham, D. M., O'Shea, P. A., Weiss, S. W. Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing's sarcoma/primitive neuroectodermal tumor. Am. J. Surg. Pathol. 25:1-12, 2001.

65. Ordonez, N. G. Desmoplastic small round cell tumor II: an ultrastructural and immunohistochemical study with emphasis on new immuno-histochemical markers. Am. J. Surg.Pathol. 22:1314-1327, 1998.

66. Charles, A. K., Moore, I. E., and Berry, P. J. Immunohistochemical detection of Wilms' tumor gene WT1 in desmoplastic small round cell tumor. Histopathology 30:312-314, 1997.

67. Taylor, C. R. and Cote, R. J. Immunohistochemical markers of prognostic value in surgical pathology. Histol. Histopathol. 12:10391055, 1997.

68. Harris, C. C. and Hollstein, M. Clinical implications of the p53 tumor-suppressor gene. N. Engl. J. Med. 329:1318-1327, 1993.

69. Harris, C. C. Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. J. Natl. Cancer. Inst. 88:1442-1455, 1996.

70. Hsu, F. D., Nielsen, T. O., Alkushi, A., et al.Tissue microarrays are an effective quality assurance tool for diagnostic immunohisto-chemistry. Mod. Pathol. 15:1374-1380, 2002.

71. Falini, B. and Mason, D. Y. Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry. Blood 99:409-426, 2002.

72. Campbell, R. J. and Pignatelli, M. Molecular histology in the study of solid tumours.Mol. Pathol. 55:80-82, 2002.

73. Gown, A. M. Geneogenic immunohistochemistry: a new era in diagnostic immunohistochemistry. Curr. Diagn. Pathol. 8:193-200, 2002.

74. Paik, S., Hazan, R., Fisher, E. R., et al. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer. J. Clin. Oncol. 8:103-112, 1990.

75. Pauletti, G., Dandekar, S., Rong, H., et al. Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry. J. Clin. Oncol. 18:3651-3664, 2000.

76. Jacobs, T. W., Gown, A. M., Yaziji, H., Barnes, M. J., and Schnitt, S. J. Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system. J. Clin. Oncol. 17:1983-1987, 1999.

77. Wang, S., Saboorian, M. H., Frenkel, E., Hynan, L., Gokaslan, S. T., and Ashfaq, R. Laboratory assessment of the status of Her-2/neu protein and oncogene in breast cancer specimens: comparison of immunohistochemistry assay with fluorescence in situ hybridisation assays. J. Clin. Pathol. 53:374-381, 2000.

78. Zarbo, R. J. and Hammond, M. E. Conference summary, Strategic Science symposium. Her-2/neu testing of breast cancer patients in clinical practice. Arch. Pathol. Lab. Med. 127:549-553, 2003.

79. Fletcher, C. D., Berman, J. J., Corless, C., et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum. Pathol. 33:459-465, 2002.

80. Hirota, S., Isozaki, K., Moriyama, Y., et al. Gain-of-function mutation of c-kit in human gastrointestinal stromal tumors. Science 279:577-580, 1998.

81. Dematteo, R. P., Heinrich, M. C., El-Rifai, W. M., and Demetri, G. Clinical management of gastrointestinal stromal tumors: before and after STI-571. Hum. Pathol. 33:466-477, 2002.

82. Greenson, J. K. Gastrointestinal stromal tumors and other mesenchymal lesions of the gut. Mod. Pathol. 16:366-375, 2003.

83. Smith, M. E. F. and Pignatelli, M. The molecular histology of neoplasia: the role of the cadherin/catenin complex. Histopathology. 31:107-111, 1997.

84. Droufakou, S., Deshmane, V., Roylance, R., Hanby, A., Tomlison, I., and Hart, I. R. Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast. Int. J. Cancer 92:404-408, 2001.

85. Chan, J. K. and Wong, C. S. Loss of E-cadherin is the fundamental defect in diffuse-type gastric carcinoma and infiltrating lobular carcinoma of the breast. Adv. Anat. Pathol. 8:165-172, 2001.

86. Marra, G. and Boland, C. R. Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J. Natl. Cancer Inst. 87:1114-1125, 1995.

87. Lindor, N. M., Burgart, L. J., Leontovich, O., et al. Immunohisto-chemistry versus microsatellite instability testing in phenotyping colorectal tumors. J. Clin. Oncol. 20:1043-1048, 2002.

88. Rigau, V., Sebbagh, N., Olschwang, S. et al. Microsatellite instability in colorectal carcinoma. The comparison of immunohistochem-istry and molecular biology suggests a role for hMLH6 immunostaining. Arch. Pathol. Lab. Med. 127:694-700, 2003.

89. Stein, H., Mason, D. Y., Gerdes, J., et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplas-tic lymphoid tissue: evidence that Reed-Sternberg cells and histio-cytic malignancies are derived from activated lymphoid cells. Blood. 66:848-858, 1985.

90. Morris, S. W., Kirstein, M. N., Valentine, M. B., et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 263:1281-1284, 1994.

91. Shiota, M., Fujimoto, J., Takenaga, M., et al. Diagnosis of t(2;5)(p23;q35)-associated Ki-1 lymphoma with immunohistochemistry. Blood 84:3648-3652, 1994.

92. Falini, B., Pulford, K., Pucciarini, A., et al. Lymphomas expressing ALK fusion protein(s) other than NPM-ALK. Blood 94:35093515, 1999.

93. Sen, F., Vega, F., and Medeiros L.J. Molecular genetic methods in the diagnosis of hematologic neoplasms. Semin. Diagn. Pathol. 19:72-93, 2002.

94. Chan, J. K., Miller, K. D., Munson, P., and Isaacson, P. G. Immunostaining for cyclin D1 and the diagnosis of mantle cell lymphoma: is there a reliable method? Histopathology. 34:266-270,1999.

95. Leong, A. S. Y., Lee, E. S., and Yin, H. Superheating antigen retrieval. Appl. Immunohistochem. Mol. Morphol. 10:263-268, 2002.

96. Kodet, R., Mrhalova, M., Krskova, L., et al. Mantle cell lymphoma: improved diagnostics using a combined approach of immunohisto-chemistry and identification of t(11;14)(q13;q32) by polymerase chain reaction and fluorescence in situ hybridization. Virchow's. Arch. 442:538-547, 2003.

97. Belaud-Rotureau, M. A., Parrens, M., Dubus, P., Garroste, J. C., de Mascarel, A., and Merlio, J. P. A comparative analysis of FISH, RT-PCR, PCR and immunohistochemistry for the diagnosis of mantle cell lymphomas. Mod. Pathol. 15:517-525, 2002.

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook

Post a comment